ClinVar Miner

Submissions for variant NM_001918.5(DBT):c.1210-10del

dbSNP: rs398123658
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000506498 SCV000111811 benign not specified 2013-08-25 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV003654413 SCV000603289 benign Maple syrup urine disease type 1A 2023-11-28 criteria provided, single submitter clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000625322 SCV000744935 benign Maple syrup urine disease 2016-02-26 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000625322 SCV001721348 benign Maple syrup urine disease 2024-01-31 criteria provided, single submitter clinical testing
GeneDx RCV001662505 SCV001874977 benign not provided 2019-09-13 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000625322 SCV004050149 benign Maple syrup urine disease 2023-04-11 criteria provided, single submitter clinical testing
Natera, Inc. RCV000625322 SCV001460677 benign Maple syrup urine disease 2020-09-16 no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV001662505 SCV001917158 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.